Yabao Pharmaceutical Group Co., Ltd (600351.SS) SHH

7.44

+0.05(+0.68%)

Updated at August 19 03:00PM

Currency In CNY

Valuation

Market Cap4.35B
Enterprise Value3.86B
P/E Ratio22.15
PEG Ratio0.22
Price/Sales Ratio2.07
Price/Book Ratio1.79
Enterprise/Revenue1.86
Enterprise/EBITDA14.51

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.09
Operating Margin0.11

Management Effectiveness

Return On Assets0.07
Return On Equity0.08

Income Statement

Revenue2.69B
Revenue/Share3.58
Gross Profit1.39B
EBITDA437.96M
Net Income242.69M
Diluted EPS0.34

Balance Sheet

Total Cash648M
Total Cash/Share0.92
Total Debt91.94M
Total Debt/Equity0.03
Current Ratio2.89
Book Value Per Share4.18

Price History

52-Week Change30.14
52-Week High8.68
52-Week Low5.1
Moving Average 50 Days6.72
Moving Average 200 Days6.29

Statistics

Average Volume35.51M
Shares Outstanding700M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield4.02
Payout Ratio0.47
Last Split Factor2:1
Last Split DateMay 28, 2010